Protagonist Therapeutics Inc (PTGX) — Cash Flow Quality Index
Protagonist Therapeutics Inc (PTGX) has a Cash Flow Quality Index of -0.22x as of December 2024. Operating cash flow of $-29.18 Million is below net income of $131.67 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore PTGX cash generation efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Protagonist Therapeutics Inc Cash Flow Quality Index (2024–2024)
Historical Cash Flow Quality Index for Protagonist Therapeutics Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Protagonist Therapeutics Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Protagonist Therapeutics Inc (2024–2024)
Year-by-year earnings quality comparison for Protagonist Therapeutics Inc. For live market cap and the full company financial profile, see Protagonist Therapeutics Inc (PTGX) market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.67x | $184.15 Million | $275.19 Million | — |